Wet Brain: Wernicke-Korsakoff Syndrome and Alcohol-Related Brain Damage

The first sign is usually something small, and it is usually reported by someone who is not a doctor. A man who has drunk heavily for twenty years starts asking the same question three times in an evening. He forgets a meal he ate an hour ago. His walk becomes wide and careful, as though the floor is moving. Then one morning he is confused in a way that does not look like drunkenness, and someone in the family says the phrase that has been circling for weeks: "wet brain."

That phrase is not a medical term, and it is often said with more fear than accuracy. The condition behind it is real, it has a name, it is diagnosed by clinicians every week, and it is one of the few alcohol-related brain injuries that can be stopped — sometimes reversed — if it is caught in time. This guide explains what Wernicke-Korsakoff syndrome is, what families actually see, why the treatment is so often given too late, and what to do in the first hours and the following months.

What Wernicke-Korsakoff Syndrome Actually Is

Wernicke-Korsakoff syndrome is not one disease but two, caused by the same deficiency of vitamin B1 — thiamine — and often occurring in sequence.

Wernicke's disease (Wernicke encephalopathy) is the acute phase. It is a neurological emergency in which thiamine deficiency damages areas of the brain that depend on rapid energy supply, most notably the thalamus, the mammillary bodies, the hippocampus and the cerebellum. These are structures involved in memory, balance, eye movement, sleep and motivation. The damage is partly reversible — but only if thiamine is replaced quickly.

Korsakoff's psychosis (Korsakoff syndrome) is the chronic phase. If the acute episode is not treated adequately, the injury consolidates into a severe and largely irreversible amnesia. The NIAAA fact sheet is blunt about this: without prompt treatment, Wernicke's disease can progress to Korsakoff's psychosis, "which is not reversible."

Why people who drink heavily become deficient is not mysterious. Chronic alcohol use reduces the gut's ability to absorb thiamine from food, depletes what the liver can store, impairs the conversion of thiamine into its active form, and usually arrives alongside a diet that supplies very little of it in the first place. The 2026 scoping review in Addiction Science & Clinical Practice puts the consequence plainly: biochemical or clinical evidence of thiamine deficiency is detectable in up to 80 percent of people with alcohol use disorder.

Alcohol is not the only route. NIAAA lists cancer, AIDS, severe vomiting in pregnancy, anorexia nervosa, dialysis, and gastrointestinal or bariatric surgery as conditions that can produce the same deficiency — far less common than alcohol, but the reason a person who has had weight-loss surgery should have thiamine monitored for at least six months afterwards, which the EFNS guideline recommends explicitly.

Why It Gets Missed: A Triad That Usually Isn't There

Medical students are taught a classic triad for Wernicke encephalopathy: confusion, unsteady gait, and abnormal eye movements. Families are often told to watch for those three things. The triad is real, and it is also the reason this condition is missed so often.

It shows up in full in only a minority of patients. Older neuropathological series found the complete triad in 16 to 20 percent of cases; more recent meta-analytic evidence suggests it is present in roughly one third of clinically identified cases. In other words, the textbook picture is the exception, and waiting for it is how the diagnosis gets delayed.

The epidemiological evidence points the same way. Neuropathological studies have found Wernicke-related lesions at autopsy in up to 12 percent of people with alcohol use disorder — including people never diagnosed during life. NIAAA notes that researchers estimate the syndrome may remain undiagnosed in approximately 80 percent of patients. Meanwhile, MRI abnormalities are reported in more than 80 percent of confirmed cases, which tells you the injury is visible; it is the clinical recognition that fails, not the imaging.

The two-of-four rule

Because the triad is too narrow, the widely used Caine criteria — adopted by the EFNS guideline, which requires two of the following four signs in a person with alcohol use disorder — lower the threshold:

• dietary deficiency or poor nutrition
• eye signs (nystagmus, ophthalmoplegia, double vision, drooping eyelid)
• cerebellar dysfunction such as an unsteady, wide-based gait
• an altered mental state or mild memory impairment

Two of those four is enough to justify treatment. Not three. Two.

The Symptoms Families Notice First

Families rarely describe a diagnosis. They describe a series of changes, and the pattern matters more than any single item.

In the acute phase, look for confusion or disorientation that is out of proportion to how intoxicated the person appears; unusual eye movements, double vision, crossed eyes or a drooping eyelid; a wide, staggering walk; drowsiness, low energy, low body temperature, or a drop in blood pressure. In severe untreated cases, coma.

In the chronic phase, the picture is dominated by memory. NIAAA describes severe, potentially irreversible impairment in forming new memories and in recalling old ones, plus confabulation — the person fills memory gaps with invented but sincerely believed detail — hallucinations, repetition of the same sentence or action, difficulty planning and organising, and a flattening of motivation that can look like depression or laziness.

The repetition is often what brings a family to the doctor. A person who asks the same question every few minutes is not being difficult; they are not retaining the answer.

What it can be mistaken for

• Alcohol withdrawal or intoxication — confusion is attributed to drinking, and the possibility of a thiamine emergency is never raised.
• Hepatic encephalopathy — the confusion of liver failure looks similar, and the two can coexist in the same patient.
• Early dementia — memory loss in a drinker is often filed as "alcohol-related dementia" without anyone checking whether a treatable thiamine deficiency is driving it.
• Depression or "not trying" — apathy and withdrawal are read as motivation, when they are symptoms.

It Is a Medical Emergency: The First 24 Hours

If a person who drinks heavily develops confusion, eye changes or a new inability to walk, that is an emergency department problem tonight, not a next-week appointment. The window matters: the EFNS guideline states that early symptoms are reversible if detected and treated promptly and completely.

Two practical points that families are rarely told:

Thiamine must come before sugar. The EFNS guideline is explicit that thiamine should be given before any carbohydrate, preferably intravenously, at 200 mg three times daily. Glucose given first — including a routine IV in an emergency department — can precipitate or worsen the acute deficiency state.

Treatment should not wait for blood tests or imaging. Thiamine levels are not available quickly in most hospitals, and the guideline says a sample should be drawn immediately before the first dose, precisely because giving it first obscures the result. MRI supports the diagnosis but must not delay treatment. The relevant question is not "is this definitely Wernicke's" but "is this person at risk and symptomatic" — and if so, the drip starts.

The guideline also makes a broader recommendation that most American families have to argue for rather than assume: parenteral (IV or injected) thiamine should be given to all at-risk patients arriving in an emergency department. And on safety, the answer is reassuring — the EFNS reviewers rate the overall safety of thiamine as very good.

The Treatment Gap: Why So Many Get a Tablet Instead of a Drip

If the diagnosis is straightforward once you look for it, and the treatment is a cheap vitamin, why does this still go wrong? A 2026 scoping review of 26 studies covering more than 44,000 people set out to answer exactly that, and its title gives away the finding: Undertreatment of Wernicke encephalopathy in alcohol-related clinical contexts.

The numbers it collected are sobering:

• In one cohort of 226 patients with alcohol use disorder, 89 percent received oral thiamine, and parenteral thiamine was underused precisely in the patients at highest risk.
• In a 565-patient French cross-sectional study, 67.1 percent of patients who actually had Wernicke symptoms were treated by the oral route.
• In a 432-patient cohort, the full guideline-concordant regimen of 500 mg three times daily was used in only 2.1 percent of cases.
• In a 443-patient Spanish cohort, only 20.9 percent received an initial dose above 300 mg per day — and delays in diagnosis and inadequate regimens were associated with worse outcomes, with an in-hospital mortality of 4.9 percent.

Route matters more than families expect, because a damaged, inflamed gut absorbs tablets poorly, and an unwell patient may not keep them down at all. The review's authors describe oral thiamine given to symptomatic patients as a central form of undertreatment, not a minor variation in style.

One honest caveat, because this field is genuinely unsettled: only two randomised trials of thiamine regimens exist, and the largest found no major dose-response effect. The review's conclusion is not "we know the perfect dose" but something more useful for a family: clinicians cannot reliably predict who will progress to Korsakoff's, parenteral thiamine is very safe, and therefore the threshold for giving it should be low. One cohort did find high-dose intravenous thiamine associated with substantially lower mortality than low-dose — 2 percent versus 13 percent — but that is observational, not proof of dose.

What Recovery Looks Like — and What Does Not Come Back

The honest answer has two halves.

The acute half is often encouraging. Eye movement abnormalities, unsteadiness and confusion frequently improve within days of adequate thiamine. That improvement is why the moment of diagnosis matters so much, and why families should not accept "we'll check his thiamine on an outpatient basis."

The chronic half is slower and less complete. Korsakoff's psychosis is defined by memory impairment that may be permanent. Treatment after the acute phase — continued thiamine, oral supplements for weeks, nutrition, hydration, and medication for specific symptoms such as psychosis — supports recovery but does not reverse structural damage. What does help is rehabilitation: memory strategies similar to those used in dementia care, routine, external memory aids, and structured daily activity. Severe cases need residential care; NIAAA says so directly.

The long view is starker than most families are prepared for. A Finnish nationwide register study followed 1,149 people diagnosed with Wernicke-Korsakoff syndrome and 2,432 with alcohol-related dementia. Incidence was 3.7 per 100,000 person-years in men and 1.2 in women, peaking between ages 50 and 59 — younger than most people expect. The standardised mortality ratio was 5.67: these patients were more than five times likelier to die during follow-up than matched adults in the general population, and most of the excess came from alcohol-related causes, concentrated in people under 65. The study's own conclusion is that these disorders are, in theory, fully preventable.

That is the argument for acting on a confused fifty-something drinker with an unsteady walk, rather than waiting to see whether he "sobers up."

The Drinking Side: Detox, Abstinence, and Medication

NIAAA is unambiguous that abstaining from alcohol is critical at every stage, to prevent and reduce further brain damage. But it adds a warning that families need to hear clearly: when someone who has drunk heavily for a long time stops suddenly, withdrawal can be painful and sometimes life-threatening. Detox should be planned with medical help, not improvised at home. Our guide to understanding detox and withdrawal management covers the mechanics, and supporting a loved one through detox covers the family's role.

Detox is also a prevention window. A 2025 review in the Journal of Psychopharmacology notes that current guidance for managing alcohol withdrawal already calls for high-dose thiamine alongside benzodiazepines, and argues that withdrawal is itself a period of heightened brain vulnerability in which thiamine deficiency amplifies oxidative injury. In practical terms: if your person is admitted for detox anywhere, "what is his thiamine regimen and by which route" is a fair question to ask on day one.

If the person is still drinking

Long-term abstinence is the intervention with the largest effect on future brain damage, and medication can help make it achievable. Naltrexone and acamprosate are evidence-based options; our medication-assisted treatment guide and alcohol addiction treatment guide walk through how they are used. Nutrition is not a soft add-on here either — thiamine-rich food and a multivitamin matter, and the nutrition and wellness guide covers it without moralising.

Supporting Someone With Korsakoff at Home

Most of the practical work of Korsakoff's falls on families, and it is easier when you stop treating the memory loss as a behaviour problem.

• Do not argue with a false memory. Confrontation produces distress and no learning. Redirect, restate the fact once, and move on.
• Build the day around routine. Meals, medication and appointments at the same times, with a visible calendar and a whiteboard by the door.
• Use external memory, not reminders. Written notes, phone alarms, labelled drawers, a single place for keys and wallet. The goal is a system that works without the person's memory.
• Check the boring safety items. Falls are a real risk with an unsteady gait; so are unattended stoves, missed medication, and driving.
• Protect yourself. Caregiver exhaustion is the norm, not a failure. Respite, support groups and, eventually, a residential placement are legitimate parts of care — not abandonment.

When home is no longer safe

Severe Korsakoff's can require supervised residential care, and NIAAA names that outcome openly. The trigger is not how much the family loves the person; it is whether the person can be kept safe from falls, fire, medication errors and exploitation. Our guide to choosing a treatment or care setting and the older-adults guide both address the conversation.

What Helps, and What Backfires

Helps: getting the person medically assessed the same day symptoms appear; asking specifically whether thiamine has been given intravenously and at what dose; insisting on a plan for the weeks after discharge; keeping alcohol out of the house and supporting abstinence; structured days and written memory aids; treating the drinking as a medical condition rather than a character flaw.

Backfires: waiting for the full triad before seeking care; accepting a bottle of oral B-complex as equivalent to a hospital protocol; letting shame keep the family silent; abrupt unsupervised withdrawal; and assuming that because the person is young, the memory will come back on its own.

Where to Get Help

• Emergency: call 911 if there is confusion with eye changes, inability to walk, seizure, or reduced consciousness.
• SAMHSA National Helpline: 1-800-662-4357, free, confidential, 24/7, English and Spanish, with treatment referrals.
• 988 Suicide & Crisis Lifeline: call or text 988 if there is hopelessness, agitation or risk of self-harm.
• FindTreatment.gov for licensed programs by ZIP code.

The Bottom Line

Wernicke-Korsakoff syndrome is a vitamin deficiency that damages the brain, and it is still missed in most of the people who have it. The acute phase is treatable and sometimes reversible; the chronic phase is not. The intervention that changes the outcome is unglamorous and time-critical: recognise two of four signs in a person who drinks heavily, get them to an emergency department, and make sure thiamine goes in intravenously before anything else. Families who know that sequence are the reason this diagnosis gets made on a Tuesday night instead of at autopsy.